Novale

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Novale

Understanding Novale

Novale is a therapeutic formulation containing ketoconazole, an antifungal agent belonging to the imidazole class. It is primarily developed for the management of fungal infections affecting the skin and scalp. By targeting the cellular structure of fungi, Novale helps to address the underlying cause of various dermatological conditions.

Mechanism of Action

The active ingredient in Novale works by interfering with the synthesis of ergosterol, a vital component of fungal cell membranes. By inhibiting the enzyme cytochrome P450 14α-demethylase, the medication disrupts the integrity of the fungal cell wall. This action leads to increased membrane permeability and eventually inhibits the growth and replication of the fungi responsible for the infection.

Primary Uses

Novale is utilized to treat a range of fungal and yeast-related skin issues. Its applications typically include:

  • Dandruff: Addressing the overgrowth of fungus-like organisms on the scalp that lead to flaking and itching.
  • Seborrheic Dermatitis: Managing inflammatory skin conditions characterized by red, scaly patches, often appearing on the face or upper body.
  • Tinea Versicolor: Treating a common fungal infection that causes small, discolored patches of skin.

Because it acts locally on the site of application, the systemic absorption of the medication is minimal, focusing its therapeutic effect on the affected dermal layers.

Regulatory References

  1. Ketoconazole - StatPearls - NCBI Bookshelf

What side effects are possible with Novale?

Possible side effects and safety information

The official safety profile for the active ingredient, ketoconazole, is categorized based on the method of administration, reflecting the significant difference between the systemic exposure of the oral tablet and the primarily localized exposure of the topical forms (cream, shampoo, gel).

Serious Adverse Reactions (Oral Tablet)

The regulatory labeling for the oral tablet highlights specific serious risks. These include the potential for fatal hepatotoxicity (severe liver injury, including liver failure and the need for transplantation), and the risk of QT prolongation (a serious heart rhythm disturbance) often resulting from contraindicated drug interactions. The oral form is also associated with adrenal insufficiency, which involves the suppression of cortisol production.

Classification Category Oral Tablet Examples Topical Form Examples
Very Common / Common Abnormal liver function tests, nausea, vomiting, abdominal pain, pruritus, rash, adrenal insufficiency. Application site burning sensation, erythema (redness), and pruritus.
System-Organ Classes Hepatobiliary, Endocrine, Gastrointestinal, Nervous System, Skin/Subcutaneous Tissue. Application Site, Skin/Subcutaneous Tissue, Immune System.

Safety-Related Restrictions and Considerations

The systemic risks necessitate strict constraints documented in the prescribing information. The oral tablet is contraindicated in patients with acute or chronic liver disease, or if pre-treatment liver enzyme levels exceed a specified threshold. It is also contraindicated during pregnancy and breastfeeding. Regulatory documents emphasize that the risk of serious liver injury is generally higher at the start of treatment and within the first six months, requiring pre-treatment and frequent monitoring of liver function.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory information describes overdose manifestations and the necessary emergency response for Novale (Ketoconazole) oral formulations. Suspected overdose is a medical emergency.

Documented Overdose Presentations

System Affected Manifestation
Gastrointestinal Nausea, vomiting, and diarrhea.
Hepatic Acute liver injury (hepatotoxicity), potentially leading to jaundice.
Endocrine Signs of adrenal insufficiency, including weakness and hypotension (low blood pressure).
Cardiovascular QT interval prolongation, with the potential for life-threatening ventricular dysrhythmias (e.g., Torsades de pointes).

Emergency Actions Mandated by Regulators

Immediate medical attention is required for any suspected overdose. Emergency services must be contacted immediately (e.g., Call 911) if the individual exhibits collapse, seizure, trouble breathing, or unconsciousness. Individuals must also contact a Poison Control Center immediately for guidance. The official treatment is symptomatic and supportive. For recent ingestion, gastric lavage with activated charcoal may be utilized. If adrenal insufficiency is observed, management includes administering hydrocortisone and monitoring fluid and electrolyte balance.

Therapeutic Uses of Novale

Novale, containing the antifungal agent ketoconazole, is commonly used across domains where additional symptomatic support is needed to help manage fungal proliferation and the resulting discomfort. It is applied in clinical settings that involve acute or unstable symptom patterns, including both localized and widespread infections.

Addressing Fungal Infections of the Skin and Scalp

Novale is applied in addressing conditions marked by increased physiological stress caused by dermatophyte infections, commonly known as ringworm (Tinea corporis), jock itch (Tinea cruris), and athlete's foot (Tinea pedis), as well as cutaneous candidiasis and Tinea versicolor. Its use is relevant when symptoms become more disruptive during flare-ups, helping to address groups of symptoms that include pronounced itching, visible redness, and the formation of scaly, peeling patches. The primary benefit is providing support that helps ease the overall symptom burden, which is relevant for easing symptoms related to inflammatory or irritative states.


Controlling Flaking and Discomfort in Seborrheic Dermatitis

The medication is commonly used across conditions characterized by periods of heightened symptoms, particularly seborrheic dermatitis, including severe dandruff. This therapeutic domain plays a role in managing symptoms that interfere with daily comfort where Malassezia yeast overgrowth contributes to chronic irritation. Novale is applied in addressing the persistent scaling, flaking, and inflammation, supporting general well-being during symptomatic phases.


Treatment for Serious Internal Fungal Diseases

In its oral form, Novale is relevant in contexts marked by increased discomfort or tension, specifically managing widespread or deep-seated fungal infections such as blastomycosis and histoplasmosis. This use is applied in scenarios where additional management of discomfort is required due to systemic illness, and is considered relevant when supportive symptom management is appropriate, assisting with maintaining functional stability during phases when symptoms become more noticeable.


Quick Fact: Relief for Inflammatory Symptoms

The medicine is used for managing conditions that produce significant symptomatic burden, including acute or recurrent infections like Tinea versicolor and fungal dermatitis. It assists with maintaining functional stability and supports patients during episodes of heightened discomfort by managing the symptoms related to inflammatory or irritative states.

“The therapeutic goal of Novale is often relevant for easing the discomfort, itching, and visible manifestations caused by pathogenic fungal overgrowth.”

Regulatory References

  1. Ketoconazole Topical: MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Novale?

The population eligibility for Novale is highly differentiated based on the form. Adults are the primary population for whom the medicine’s use, both oral and topical, is established. For the oral tablet, safety and effectiveness are not established in children under 2 years of age, and use is generally not recommended in this group.

The use of Novale is strictly defined by regulatory contraindications, particularly concerning the oral tablet due to systemic risks. Absolute prohibitions apply to patients with acute or chronic liver disease due to the risk of severe hepatotoxicity. Furthermore, the oral tablet is contraindicated if used concurrently with specific medications that can prolong the heart's QT interval, posing a cardiac risk.

Absolute Contraindications

  • Acute or Chronic Liver Disease (Oral Tablet)
  • Known Hypersensitivity to ketoconazole or any component (All forms)
  • Pregnancy (Oral Tablet)
  • Concurrent Use of Specific QT-Prolonging Drugs (Oral Tablet)

Topical forms are less restricted but require caution during lactation, where application to the breast area should be avoided.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

Novale's interaction profile is primarily defined by its ability to act as a potent inhibitor of the CYP3A4 enzyme system and certain drug efflux transporters. This pharmacological action significantly reduces the body's clearance of many co-administered medicines, leading to elevated plasma concentrations.

Formal Contraindications

Co-administration is strictly contraindicated with certain drugs due to the high risk of severe adverse events. Prohibited combinations include several QT-prolonging agents (e.g., Dofetilide, Quinidine), HMG-CoA reductase inhibitors that risk rhabdomyolysis ( Simvastatin, Lovastatin), and certain oral benzodiazepines (e.g., Oral Midazolam) due to potentiated sedative effects.

Administration Constraints

Category Constraint or Requirement
Acid-Reducing Agents Administration must be separated by at least two hours from Novale tablets, as reduced gastric acidity impairs Novale’s absorption.
Liver Disease Use is formally contraindicated in patients with acute or chronic hepatic disease due to the risk of severe toxicity.
Exposure-Altering Drugs Close monitoring and mandatory dose reduction are required for drugs like Tacrolimus and Sildenafil, whose systemic exposure is significantly increased.
Substance Interaction Consumption of alcohol is restricted due to the documented risk of liver damage and a potential disulfiram-like reaction.

Mechanism of Action

Novale employs a dual-mechanism approach to modulate nerve signaling, primarily targeting pathways involved in the transmission of peripheral nerve signals.

Regulation of Electrical Signaling via Na^+ Channels

Novale's primary action is as a state-dependent blocker of voltage-gated Na^+ channels (specifically Na V1.7 and Na V1.8) on peripheral sensory neurons. This mechanism restricts the influx of Na^+ ions essential for action potential generation, resulting in the maintenance of the channel in the inactivated state, which reduces the propensity for high-frequency action potential generation.

Modulation of Chemical Signaling via the CaSR

Novale's synergistic action is as a positive allosteric modulator of the Ca^2+-sensing receptor ( CaSR). CaSR activation initiates an intracellular signaling cascade that limits the synthesis and release of pronociceptive neuropeptides ( CGRP, substance P) from the nerve terminal. This action decreases the concentration of specific pronociceptive neuropeptides released at the nerve terminal.

The Mechanistic Cascade: From Molecule to System

The combined effect initiates a mechanistic cascade where molecular blockade and receptor modulation lead to a reduction in peripheral nerve excitability and suppressed neurotransmitter release. This sequence modifies molecular steps that influence peripheral signal conduction and reduces the overall output of sensory afferent activity.

Dosage and Administration Information

Instructions for Using Novale

These guidelines outline the administration requirements for Novale. Patients should follow these instructions precisely, as they define the method for taking the medicine.


Administration Requirements

Requirement Instruction
Route of Administration Take orally (by mouth).
Dosing Schedule Take one tablet once daily.
Timing in Relation to Meals May be taken with or without food.
Preparation The tablet must be swallowed whole; no crushing, splitting, or chewing is specified or required.
Age Group Use is approved for patients 18 years of age and older.

Procedural Steps and Missed Dose Rules

Procedural Structure: The use protocol is structured around consistent daily intake. The patient must administer the prescribed dose at approximately the same time each day to maintain a regular dosing interval, as defined in the regimen.

Missed Dose Instructions:

  1. If a dose is missed, take the dose as soon as possible on the same day.
  2. However, if it is almost time for the next scheduled dose (e.g., within 12 hours of the next dose time for a once-daily drug), the patient must skip the missed dose entirely.
  3. The patient must then resume the regular dosing schedule and must not take two doses to compensate for the missed dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Novale

This overview describes the official research evidence that exists for Novale (Ketoconazole), detailing the types of studies conducted and the general patterns observed, while clearly outlining areas where evidence is still emerging or insufficient. The information provided is strictly descriptive and does not constitute medical advice or a recommendation for use.


Evidence for Use in Seborrheic Dermatitis (Topical Forms)

Research exploring seborrheic dermatitis has primarily involved short-term Randomized Controlled Trials ( RCTs) and systematic reviews in adults and adolescents. These studies were applied in research contexts involving fluctuating or unstable symptoms. Researchers explored various outcomes, focusing on measurements of fungal clearance (mycological cure) and clinical outcomes such as scaling, redness, and patient-reported outcomes describing perceived discomfort like itching ( pruritus). Findings describe patterns observed over defined time intervals, typically 2 to 4 weeks. Research describes the consistency of the study measurements for this specific short-term application.


Evidence for Use in Tinea Infections (Topical Forms)

Novale was studied in research examining localized Tinea infections (e.g., athlete's foot). The research involved short-term RCTs designed to observe responses over defined time intervals. These studies explored primary outcomes related to systemic or functional imbalance, such as measurement of mycological status and clinical success markers (resolution of signs like fissuring and scaling) in study populations composed mostly of adults with uncomplicated forms of the infection.


Key Gaps and Uncertainty in Novale Research

Research describes that follow-up durations were limited in the pivotal topical studies, indicating what is still uncertain regarding outcomes over a period of many months. A key limitation described in regulatory reports is the composition of the research base, which includes studies often comparing the compound only to a vehicle (placebo) rather than to a range of current alternative topical treatments. Additionally, subgroup findings are uncertain for several populations; research has included adolescents, but data for younger children remain insufficient. The evidence for the oral form is composed of older clinical data that presents challenges when assessed against the rigorous standards of current efficacy and safety evaluation.

Frequently Asked Questions (FAQ)

Common questions about Novale (FAQ)


Q: What happens if I forget to use Novale one day?

Regulatory guidance indicates that the dose is taken as soon as possible on the same day. However, if it is almost time for the next scheduled dose (for instance, within 12 hours of the next time), the missed dose is skipped entirely, and taking two doses to compensate is avoided.


Q: Can I take Novale if I'm already taking supplements?

Regulatory documents indicate that the active ingredient in Novale can significantly alter the blood levels of many co-administered substances. This potential interaction applies not only to other prescription medications but also to over-the-counter medicines, vitamins, and herbal products (commonly referred to as supplements). Official guidance emphasizes the importance of a healthcare provider being informed about all substances, including supplements, currently being taken.


Q: Does Novale interact with alcohol?

Yes, official product information includes a restriction on alcohol consumption. Using the oral tablet while consuming alcohol is restricted because of a documented risk of liver damage and the potential for a severe reaction known as a disulfiram-like effect.


Q: Can I take over-the-counter cold medicine with Novale?

The drug is known to interact with many medicines because it changes how the body clears them from the bloodstream. Official documents note that this includes both prescription and over-the-counter (OTC) medicines. Because of the risk of elevated blood levels of certain OTC ingredients, official guidance emphasizes that the use of all cold medicines be discussed with a healthcare provider.


Q: What happens when I stop using Novale?

Regulatory information for patients emphasizes the importance of treatment consistency. Official patient information notes that stopping Novale is not done without first speaking with a healthcare provider. This ensures that the patient’s condition is managed appropriately and that the discontinuation process, if necessary, is monitored.


Q: Is it common to feel tired when starting Novale?

Official adverse event reports do not list general tiredness as a common, minor side effect. However, regulatory documents state that unusual fatigue or tiredness can be a symptom associated with serious adverse events, such as liver damage or adrenal insufficiency. Regulatory documents state that persistent or concerning fatigue is reported to a healthcare professional.


Q: How quickly does Novale usually start to work?

The time it takes for a person to notice an effect is variable. Clinical studies for topical forms of Novale, such as those used for skin or scalp infections, often observed outcomes over defined time intervals, typically lasting 2 to 4 weeks. This suggests that measurable change was observed within this period during the conditions studied.


Q: Can Novale impact my ability to drive?

Regulatory documents indicate that the oral tablet may cause side effects, such as dizziness or headache. Some official labels include a dedicated section on the effects on the ability to drive and use machines, advising caution until a person knows how the medicine affects them.


Q: Is it normal to have mild headaches when adjusting to Novale?

Yes, regulatory documents list headache as a common adverse reaction for the oral tablet form. This information is based on data collected during clinical trials.


Q: Is Novale a painkiller or something else?

Novale is fundamentally defined by its active ingredient, which is classified as an Imidazole Antifungal (Antimycotic). This means it is specialized for addressing pathogenic fungal organisms by disrupting their cell structure, and it is not categorized as a medicine for pain relief.


Q: Why is Novale prescribed for [Condition A] when people also mention [Condition B]?

Official labeling defines the conditions for which the drug is formally indicated for treatment. The FDA has specifically limited the use of the oral tablet to certain severe fungal infections only when other therapies are unavailable or not tolerated. This ensures the medicine is used strictly for its intended purpose as defined by regulatory bodies.


Q: How long can a person expect to use Novale?

The duration of use is not uniform for all patients. Official information states that Novale is sometimes used for short-term treatment, but in other cases, especially for systemic conditions, it may need to be taken for several months.


Q: Is Novale available in different strengths?

According to official product information, the Novale oral tablet form is available in a single regulatory strength of 200 mg.


Q: Are there any specific foods or drinks to avoid while using Novale?

Official documents explicitly advise avoiding consumption of grapefruit and grapefruit juice. These products can interfere with the metabolism of the active ingredient, potentially increasing the blood levels of the drug.


Q: Do older adults typically use Novale?

The product is approved for adult patients. Official labeling, such as the FDA's 'Use in Specific Populations' section, may contain statements indicating that no overall differences in safety or effectiveness were observed between older and younger subjects in the clinical trials that were conducted.


Q: Can men and women use Novale equally?

The oral tablet can be used by both men and women, but official documentation notes a specific effect in men. High doses are known to lower serum testosterone and decrease certain corticosteroid levels. This effect is generally noted to return to baseline after the medicine is discontinued.


Q: Does Novale affect energy levels?

The oral tablet is associated with adrenal insufficiency as a possible serious adverse reaction. Adrenal insufficiency involves the suppression of cortisol production, which can lead to symptoms such as weakness, tiredness, or lack of energy.


Q: What is the earliest age a person can be prescribed Novale?

Official regulatory guidance states that the use of the oral tablet is generally not recommended in young children. The safety and effectiveness have not been established for those younger than 2 years of age, and its use is approved starting at age 18 for most systemic treatments.


Q: What kind of studies support the use of Novale?

Research supporting the use of Novale has primarily involved short-term Randomized Controlled Trials ( RCTs) for its various topical forms. These studies focused on measurable results like mycological cure (clearance of fungus) and clinical markers such as the resolution of scaling and redness.


Q: Why do official documents emphasize the importance of monitoring while using Novale?

Monitoring is highly emphasized because the oral tablet carries a risk of serious adverse reactions, including fatal hepatotoxicity (severe liver injury). Official documents state this risk is generally higher at the start of treatment and within the first six months, requiring frequent monitoring of liver function.


Q: Has Novale been recalled or is it under any special watch?

The FDA issued a safety communication and a Boxed Warning on the oral tablet due to the risk of potentially fatal liver injury and harmful drug interactions. This action led to a limit on its approved usage rather than a broad recall, indicating strict caution must be observed.


Q: What should I do if a side effect seems serious?

Official patient information indicates that a healthcare provider is called immediately if any signs of serious side effects are experienced. This includes symptoms such as signs of liver damage (like dark urine, pale stools, or severe fatigue) or a severe skin reaction.


Q: Are there any known interactions between Novale and herbal remedies?

Yes, official regulatory documents explicitly mention that herbal products can interfere with Novale. This is due to the drug's mechanism of interaction, which can alter the blood levels of many co-administered substances, including herbal remedies.


Q: Does Novale have any sedative effects?

Regulatory documents state that co-administration with certain central nervous system (CNS) depressants, such as oral benzodiazepines, is contraindicated because it can cause potentiated and prolonged hypnotic and sedative effects. This relates to an interaction, not a primary sedative effect of Novale alone.


Q: Can Novale interact with acid reflux medications?

Yes, the use of acid-reducing agents can impair the absorption of the drug. Because of this, official administration constraints require that the taking of the oral tablet must be separated by at least two hours from acid-reducing medications.

How should Novale be stored and disposed of?

Storage and Disposal Requirements

Novale (ketoconazole) must be stored according to official regulatory guidelines to maintain its stability and integrity.

Storage Conditions

Most forms, including the oral tablet, cream, and foam, must be stored at Controlled Room Temperature, 20 C to 25 C (68 F to 77 F). The product must be actively protected from moisture and direct light and must not be frozen. The original container should be used and kept tightly closed. The foam formulation is flammable and must be kept away from excessive heat or open flames.

Child Safety and Disposal

It is mandatory to keep all forms of Novale out of the sight and reach of children. Disposal of unused or expired medication should utilize an official drug take-back program. If a program is unavailable, the product must be mixed with an undesirable substance, placed in a sealed container, and discarded in the household trash. The medication must not be flushed down the sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Novale found in:

A-Z Index: